We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Antiaging Gene SIRT6 Shown to Suppress Cancer in Lab Mice

By LabMedica International staff writers
Posted on 17 Dec 2012
A new study provides new clues into how a pro-longevity gene inhibits cancer growth.

New findings show that the loss of the SIRT6 protein in mice increases the size, number, and aggressiveness of tumors. More...
The research also suggests that the loss of SIRT6 promotes tumor growth in human colon and pancreatic cancers.

The study’s findings were published December 7, 2012, in the journal Cell. “It is critical to understand the spectrum of genes that suppress tumor development,” said cosenior author David Lombard, MD, PhD, assistant professor of pathology and assistant research professor at the University of Michigan (U-M) Institute of Gerontology at the U-M Medical School (Ann Arbor, MI, USA). “Our research suggests SIRT6 may have a critical role in blocking cancer and controlling cellular metabolism. We hope to build on this work to better understand how this protein suppresses tumor development, and provide insight into potential future means of reprogramming cancer metabolism.”

The research was conducted in conjunction with the Massachusetts General Hospital Cancer Center at Harvard Medical School (Boston, MA, USA). Raul Mostoslavsky, MD, PhD, assistant professor of medicine at Harvard Medical School, was the cosenior author. The new research focusses on the role SIRT6 plays in suppressing cancer growth by repressing aerobic glycolysis--a key feature of cancer cells that involves the conversion of glucose to lactate. SIRT6 also dampens activity of the significant cancer gene Myc.

Many cancer biology studies have targeted in on the significance of tumor-suppressor proteins and how they may protect cells from developing into cancer. The new study follows up on earlier research that had linked SIRT6 to longevity in male mice. Other research has also demonstrated that the protein may protect against obesity caused by diet.

“This work points to the conservation of biological mechanisms between lower organisms and humans, and the importance of fundamental basic research,” concluded Dr. Lombard, a researcher at the U-M Comprehensive Cancer Center. “This family of proteins was originally studied in yeast. It turns out to have key roles in promoting mammalian health.”

Related Links:

University of Michigan Medical School
Massachusetts General Hospital Cancer Center at Harvard Medical School



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.